262 related articles for article (PubMed ID: 18155831)
21. [Effects of hFRNK on E-cadherin/beta-catenin in colon cancer cells in vitro].
Cao J; Yu JP; Liu CH; Chen XW; Liu S; Luo HS; Yu HG
Zhonghua Zhong Liu Za Zhi; 2007 May; 29(5):346-50. PubMed ID: 17892129
[TBL] [Abstract][Full Text] [Related]
22. Induction of E-cadherin endocytosis by loss of protein phosphatase 2A expression in human breast cancers.
Suzuki K; Takahashi K
Biochem Biophys Res Commun; 2006 Oct; 349(1):255-60. PubMed ID: 16930554
[TBL] [Abstract][Full Text] [Related]
23. Ezrin interacts with cortactin to form podosomal rosettes in pancreatic cancer cells.
Kocher HM; Sandle J; Mirza TA; Li NF; Hart IR
Gut; 2009 Feb; 58(2):271-84. PubMed ID: 18852256
[TBL] [Abstract][Full Text] [Related]
24. Up-regulation of E-cadherin by small activating RNA inhibits cell invasion and migration in 5637 human bladder cancer cells.
Mao Q; Li Y; Zheng X; Yang K; Shen H; Qin J; Bai Y; Kong D; Jia X; Xie L
Biochem Biophys Res Commun; 2008 Oct; 375(4):566-70. PubMed ID: 18725195
[TBL] [Abstract][Full Text] [Related]
25. Serum response factor enhances liver metastasis of colorectal carcinoma via alteration of the E-cadherin/beta-catenin complex.
Choi HN; Kim KR; Lee JH; Park HS; Jang KY; Chung MJ; Hwang SE; Yu HC; Moon WS
Oncol Rep; 2009 Jan; 21(1):57-63. PubMed ID: 19082443
[TBL] [Abstract][Full Text] [Related]
26. Small interfering RNA-directed targeting of Toll-like receptor 4 inhibits human prostate cancer cell invasion, survival, and tumorigenicity.
Hua D; Liu MY; Cheng ZD; Qin XJ; Zhang HM; Chen Y; Qin GJ; Liang G; Li JN; Han XF; Liu DX
Mol Immunol; 2009 Sep; 46(15):2876-84. PubMed ID: 19643479
[TBL] [Abstract][Full Text] [Related]
27. Ezrin is a key molecule in the metastasis of MOLT4 cells induced by CCL25/CCR9.
Zhou B; Leng J; Hu M; Zhang L; Wang Z; Liu D; Tong X; Yu B; Hu Y; Deng C; Liu Y; Zhang Q
Leuk Res; 2010 Jun; 34(6):769-76. PubMed ID: 20036004
[TBL] [Abstract][Full Text] [Related]
28. [The effects of shRNA-CXCR4 on breast cancer cells migration and invasion].
Li HY; Ren GS; Tan JX
Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 May; 40(3):393-7. PubMed ID: 19626989
[TBL] [Abstract][Full Text] [Related]
29. Tumor-specific RNAi targeting eIF4E suppresses tumor growth, induces apoptosis and enhances cisplatin cytotoxicity in human breast carcinoma cells.
Dong K; Wang R; Wang X; Lin F; Shen JJ; Gao P; Zhang HZ
Breast Cancer Res Treat; 2009 Feb; 113(3):443-56. PubMed ID: 18327707
[TBL] [Abstract][Full Text] [Related]
30. Knockdown of STAT3 expression by RNA interference inhibits the induction of breast tumors in immunocompetent mice.
Ling X; Arlinghaus RB
Cancer Res; 2005 Apr; 65(7):2532-6. PubMed ID: 15805244
[TBL] [Abstract][Full Text] [Related]
31. Extracellular cleavage and shedding of P-cadherin: a mechanism underlying the invasive behaviour of breast cancer cells.
Ribeiro AS; Albergaria A; Sousa B; Correia AL; Bracke M; Seruca R; Schmitt FC; Paredes J
Oncogene; 2010 Jan; 29(3):392-402. PubMed ID: 19901964
[TBL] [Abstract][Full Text] [Related]
32. Effects of raf kinase inhibitor protein expression on metastasis and progression of human breast cancer.
Li HZ; Gao Y; Zhao XL; Liu YX; Sun BC; Yang J; Yao Z
Mol Cancer Res; 2009 Jun; 7(6):832-40. PubMed ID: 19531568
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of rho-associated kinase signaling prevents breast cancer metastasis to human bone.
Liu S; Goldstein RH; Scepansky EM; Rosenblatt M
Cancer Res; 2009 Nov; 69(22):8742-51. PubMed ID: 19887617
[TBL] [Abstract][Full Text] [Related]
34. Repressed E-cadherin expression in the lower crypt of human small intestine: a cell marker of functional relevance.
Escaffit F; Perreault N; Jean D; Francoeur C; Herring E; Rancourt C; Rivard N; Vachon PH; Paré F; Boucher MP; Auclair J; Beaulieu JF
Exp Cell Res; 2005 Jan; 302(2):206-20. PubMed ID: 15561102
[TBL] [Abstract][Full Text] [Related]
35. A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential.
Fritzmann J; Morkel M; Besser D; Budczies J; Kosel F; Brembeck FH; Stein U; Fichtner I; Schlag PM; Birchmeier W
Gastroenterology; 2009 Jul; 137(1):165-75. PubMed ID: 19328798
[TBL] [Abstract][Full Text] [Related]
36. [Expression of Ezrin in gastric carcinoma and its significance].
Shi RL; Li JF; Qu Y; Chen XH; Gu QL; Zhu ZG; Liu BY
Zhonghua Wei Chang Wai Ke Za Zhi; 2006 Sep; 9(5):433-5. PubMed ID: 17043968
[TBL] [Abstract][Full Text] [Related]
37. Downregulation of β-catenin decreases the tumorigenicity, but promotes epithelial-mesenchymal transition in breast cancer cells.
Cai K; Jiang L; Wang J; Zhang H; Wang X; Cheng D; Dou J
J Cancer Res Ther; 2014; 10(4):1063-70. PubMed ID: 25579555
[TBL] [Abstract][Full Text] [Related]
38. miR-145-dependent targeting of junctional adhesion molecule A and modulation of fascin expression are associated with reduced breast cancer cell motility and invasiveness.
Götte M; Mohr C; Koo CY; Stock C; Vaske AK; Viola M; Ibrahim SA; Peddibhotla S; Teng YH; Low JY; Ebnet K; Kiesel L; Yip GW
Oncogene; 2010 Dec; 29(50):6569-80. PubMed ID: 20818426
[TBL] [Abstract][Full Text] [Related]
39. Downregulation of miR-193b contributes to enhance urokinase-type plasminogen activator (uPA) expression and tumor progression and invasion in human breast cancer.
Li XF; Yan PJ; Shao ZM
Oncogene; 2009 Nov; 28(44):3937-48. PubMed ID: 19701247
[TBL] [Abstract][Full Text] [Related]
40. Silencing of cyclooxygenase-2 inhibits metastasis and delays tumor onset of poorly differentiated metastatic breast cancer cells.
Stasinopoulos I; O'Brien DR; Wildes F; Glunde K; Bhujwalla ZM
Mol Cancer Res; 2007 May; 5(5):435-42. PubMed ID: 17510310
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
